Hiwa Ramadhan Fatah
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hiwa Ramadhan Fatah has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Fikry Ali Qadir
Department of Biology, College of Science, Salahaddin University-Erbil, Erbil 44001, Kurdistan Region, Iraq
1 shared publication - Hanaa Ali Muhammad
Department of Biology, Faculty of Science and Health, Koya University, Koya 44023, Kurdistan Region—F.R., Iraq
1 shared publication - Hanan Tariq Subhi
Department of Biology, Faculty of Science and Health, Koya University, Koya KOY45, Kurdistan Region – F.R. Iraq
1 shared publication - Jutyar I. Saber1 shared publication
Latest Publications
- Open Access
- 20 January 2026
- Published by Koya University in ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY
- Vol. 14 (1) , 165-174
Molecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
Globally, prostate cancer (PCa) is becoming more prevalent and lethal. The progression of PCa is linked to both inflammation and angiogenesis. Pro-inflammatory cytokines, interleukin (IL)-8) and vascular endothelial growth factor (VEGF), promote inflammation, angiogenesis, and PCa progression. On the other hand, IL-27 (IL-27) has antitumor effects, modulates immune system activity, and thus serves as a suppressor of tumor growth. In the Kurdistan Region of Iraq, there is limited evidence linking these cytokines and their gene polymorphisms to PCa. This case–control study included 50 PCa patients and 30 age-matched healthy controls. Serum levels of these three cytokines were evaluated by enzyme-linked immunosorbent assay, whereas PCR and Sanger sequencing were used to find polymorphisms in IL-8 (rs4073, rs2227306), IL-27 (rs153109), and VEGF (rs2010963) in formalin-fixed paraffinembedded tissue DNA. GeneMANIA was used to assess gene-gene interaction networks. Statistical analyses were performed using Mann–Whitney U tests. Patients with PCa showed elevated IL-8 and VEGF levels and reduced IL-27 levels compared to controls (p < 0.05). Multiple single-nucleotide polymorphisms were found in all target genes, several of which were new to the GenBank. Gene-network analysis revealed that these three cytokines are involved in shared inflammatory, immunomodulatory, and angiogenic pathways. This study shows that altered serum levels and gene polymorphisms of these three cytokines may be biomarkers for PCa diagnosis and progression. It underlines the molecular interplay between inflammatory and angiogenic mediators and supports further cytokine-based diagnostic and therapeutic research.
- 20 January 2026
- Published by Koya University in ARO-THE SCIENTIFIC JOURNAL OF KOYA UNIVERSITY
- Vol. 14 (1) , 165-174
Open AccessMolecular Evaluation of Interleukin-8, Interleukin-27, and Vascular Endothelial Growth Factor Expression in Prostate Cancer Patients
Globally, prostate cancer (PCa) is becoming more prevalent and lethal. The progression of PCa is linked to both inflammation and angiogenesis. Pro-inflammatory cytokines, interleukin (IL)-8) and vascular endothelial growth factor (VEGF), promote inflammation, angiogenesis, and PCa progression. On the other hand, IL-27 (IL-27) has antitumor effects, modulates immune system activity, and thus serves as a suppressor of tumor growth. In the Kurdistan Region of Iraq, there is limited evidence linking these cytokines and their gene polymorphisms to PCa. This case–control study included 50 PCa patients and 30 age-matched healthy controls. Serum levels of these three cytokines were evaluated by enzyme-linked immunosorbent assay, whereas PCR and Sanger sequencing were used to find polymorphisms in IL-8 (rs4073, rs2227306), IL-27 (rs153109), and VEGF (rs2010963) in formalin-fixed paraffinembedded tissue DNA. GeneMANIA was used to assess gene-gene interaction networks. Statistical analyses were performed using Mann–Whitney U tests. Patients with PCa showed elevated IL-8 and VEGF levels and reduced IL-27 levels compared to controls (p < 0.05). Multiple single-nucleotide polymorphisms were found in all target genes, several of which were new to the GenBank. Gene-network analysis revealed that these three cytokines are involved in shared inflammatory, immunomodulatory, and angiogenic pathways. This study shows that altered serum levels and gene polymorphisms of these three cytokines may be biomarkers for PCa diagnosis and progression. It underlines the molecular interplay between inflammatory and angiogenic mediators and supports further cytokine-based diagnostic and therapeutic research.
- Open Access
- 13 July 2022
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2022, 1-18
Effect of New 2-Thioxoimidazolidin-4-one Compounds against Staphylococcus aureus Clinical Strains and Immunological Markers’ Combinations
Although the structure-activity relationship indicates that the 4-thioxoimidazolidin ring is essential for antibacterial activities and pharmaceutical applications, there were no enough studies on the derivatives of this compound. Evaluating the new hydantoin compounds C5 (3-((2-bromobenzylidene) amino)-2- thioxoimidazolidin-4-one) and C6 (3-((4- methoxybenzylidene) amino)-2-thioxoimidazolidin-4-one) that were prepared against clinical Staphylococcus aureus isolates for antibacterial, antibiofilm, and antihemagglutination activities is the aim of this study. Therefore, the potential clinical resistance of the strains was evaluated by their ability to form biofilms, antibiotic resistance, and agglutinate erythrocytes macroscopically and microscopically; besides, the bacterial biofilm was screened for any association with the patients serum immunoglobulin levels and complements. Despite the effective concentration for C5 and C6 compounds, which is31.25μg/ml, the reduction rate is not concentration-dependent; it depends on the molecular docking of the hydantoin compounds. Hence, the effect of the minimal inhibitory concentrations (MICs) is variable. In this study, the results for the compounds (with the concentration of 31.2562.5μg/mL for C5 and 62.5125μg/mL for C6) significantly manifest the antibacteria, antibiofilm, and antihemagglutination effects against the virulent strains of S. aureus due to the high percentage of biofilm inhibition that was caused by the new hydantoin compounds. Besides, time-kill kinetics studies showed that these compounds pose bactericidal action. Overall, this study revealed that the new hydantoin derivatives have an interesting potential as new antibacterial drugs through the inhibition of bacterial adhesion. The infections of these isolates activate the complement system through the lectin pathway. Nevertheless, these compounds can be improved in order to be used at even lower concentrations.
- 13 July 2022
- Published by Wiley in Canadian Journal of Infectious Diseases and Medical Microbiology
- Vol. 2022, 1-18
Open AccessEffect of New 2-Thioxoimidazolidin-4-one Compounds against Staphylococcus aureus Clinical Strains and Immunological Markers’ Combinations
Although the structure-activity relationship indicates that the 4-thioxoimidazolidin ring is essential for antibacterial activities and pharmaceutical applications, there were no enough studies on the derivatives of this compound. Evaluating the new hydantoin compounds C5 (3-((2-bromobenzylidene) amino)-2- thioxoimidazolidin-4-one) and C6 (3-((4- methoxybenzylidene) amino)-2-thioxoimidazolidin-4-one) that were prepared against clinical Staphylococcus aureus isolates for antibacterial, antibiofilm, and antihemagglutination activities is the aim of this study. Therefore, the potential clinical resistance of the strains was evaluated by their ability to form biofilms, antibiotic resistance, and agglutinate erythrocytes macroscopically and microscopically; besides, the bacterial biofilm was screened for any association with the patients serum immunoglobulin levels and complements. Despite the effective concentration for C5 and C6 compounds, which is31.25μg/ml, the reduction rate is not concentration-dependent; it depends on the molecular docking of the hydantoin compounds. Hence, the effect of the minimal inhibitory concentrations (MICs) is variable. In this study, the results for the compounds (with the concentration of 31.2562.5μg/mL for C5 and 62.5125μg/mL for C6) significantly manifest the antibacteria, antibiofilm, and antihemagglutination effects against the virulent strains of S. aureus due to the high percentage of biofilm inhibition that was caused by the new hydantoin compounds. Besides, time-kill kinetics studies showed that these compounds pose bactericidal action. Overall, this study revealed that the new hydantoin derivatives have an interesting potential as new antibacterial drugs through the inhibition of bacterial adhesion. The infections of these isolates activate the complement system through the lectin pathway. Nevertheless, these compounds can be improved in order to be used at even lower concentrations.